Real-time enrollment status for this macular degeneration clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT05407636 |
| Recruiting Status | Recruiting |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 660 participants |
| Active Locations | 107 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | September 25, 2025 (Sep 25, 2025) |
As of March 2, 2026: Clinical trial NCT05407636 is currently recruiting participants. This clinical trial study for macular degeneration is actively seeking new participants at 107 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05407636 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 107 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05407636 was last updated Sep 25, 2025 (September 25, 2025). HelloStudys verifies this status automatically.